BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17223908)

  • 1. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
    Kaplan B; Livneh A; Gallo G
    Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
    Noel LH; Droz D; Ganeval D; Grunfeld JP
    Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary light chain deposition disease: report of five cases and review of the literature.
    Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
    Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Apr; 245(3):713-6. PubMed ID: 9588180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
    Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
    Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis of pancreatic islets in primary amyloidosis (AL type).
    Tomita T
    Pathol Int; 2005 Apr; 55(4):223-7. PubMed ID: 15826250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
    Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
    Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
    Buxbaum J; Gallo G
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis.
    Hemmer PR; Topazian MD; Gertz MA; Abraham SC
    Am J Surg Pathol; 2007 Jan; 31(1):141-5. PubMed ID: 17197930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits.
    Rekhtman N; Hash KS; Moresi JM
    Br J Dermatol; 2006 Apr; 154(4):751-4. PubMed ID: 16536823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases.
    Khoor A; Myers JL; Tazelaar HD; Kurtin PJ
    Am J Clin Pathol; 2004 Feb; 121(2):200-4. PubMed ID: 14983932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.